Digital decision support and remote patient monitoring may improve outcomes and efficiency, but rarely scale beyond a single institution. Over the last 5 years, the platform Timely Interventions for Diabetes Excellence (TIDE) has been associated with reduced care provider screen time and improved, equitable type 1 diabetes care and outcomes for 268 patients in a heterogeneous population as part of the Teamwork, Targets, Technology, and Tight Control (4T) Study (NCT03968055, NCT04336969). Previous efforts to deploy TIDE at other institutions continue to face delays. In partnership with the diabetes technology non-profit, Tidepool, we developed Tidepool-TIDE, a clinic-agnostic, turnkey solution available to any clinic in the United States. We present how we overcame common technical and operational barriers specific to scaling digital health technology from one site to many. The concepts described are broadly applicable for institutions interested in facilitating broader adoption of digital technology for population-level management of chronic health conditions.

数字决策支持和远程患者监测可能会改善结果和效率，但很少扩展到单个机构之外。在过去的 5 年中，作为团队合作、目标、技术和严格控制 （4T） 研究 （NCT03968055， NCT04336969） 的一部分，Timely Interventions for Diabetes Excellence （TIDE） 平台与减少护理提供者的屏幕时间以及改善、公平的 1 型糖尿病护理和结果有关，这些患者来自不同人群中的 268 名患者。之前在其他机构部署 TIDE 的努力继续面临延误。我们与糖尿病技术非营利组织 Tidepool 合作，开发了 Tidepool-TIDE，这是一种与诊所无关的交钥匙解决方案，可供美国的任何诊所使用。我们介绍了我们如何克服常见的技术和运营障碍，将数字健康技术从一个站点扩展到多个站点。所描述的概念广泛适用于有兴趣促进更广泛采用数字技术进行慢性健康状况人口层面管理的机构。